Skip to content

A Study to understand the prognosis of Prameha(Diabetes Mellitus)

A Conceptual & Clinical Study of SÄ?dhya-AsÄ?dhyatÄ? of Prameha

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/012203
Enrollment
60
Registered
2018-02-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diabetic Patients with Fasting Blood Sugar 126mg/dl-250mg/dl not having any other systemic illness

Interventions

Intervention1: Oral Administration of Bhunimbadi Churna: A Pramehahar Yoga as per Charaka Samhita Chikitsa Sthana 15/132 was administered orally in a dose of 4gm thirce a day before meals with lukewar

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: DM II, presenting with FBS : 126-250 mg/dl Willingly to sign the consent form for clinical trial and agreed to participate religiously.

Exclusion criteria

Exclusion criteria: Patient having any other illness. Drug induced diabetes mellitus Gestational DM

Design outcomes

Primary

MeasureTime frame
Turbidity in Urine, Glycosuria, Increased thirst, Increased appetite, Perspiration, Polyuria, Numbness, Fasting Blood Sugar, Postprandial Blood Sugar, CBC at starting of trial and after 60 daysTimepoint: before the trial and after the completion of the trial

Secondary

MeasureTime frame
FBS at every 20 daysTimepoint: 20 days

Countries

India

Contacts

Public ContactKonica Gera

National Institute of Ayurveda, Jaipur

drkonica.109@gmail.com9015903900

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026